Imbruvica Replaces Chemo, Darzalex Boosts Standard Of Care In Front-Line CLL, Myeloma

 
• By Mandy Jackson
  
Tait Shanafelt AT American Society of Hematology
Tait Shanafelt of the Stanford University School of Medicine • Source: Courtesy of ASH
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D